Allergan Beauty Company, a subsidiary of AbbVie, has signed an agreement to acquire Israel’s Luminera, a privately-owned beauty company that develops dermal filler products.
The American company said in a statement that under the terms of the agreement, Allergan Beauty will acquire Luminera’s complete dermal filler portfolio and R&D pipeline, which will complement Allergan’s existing beauticians Dermal filler combination. No financial details were disclosed, but the Globes financial website estimated that the transaction was worth hundreds of millions of dollars.
Luminera was founded in 2013 and is headquartered in Lord, Israel. It is a manufacturer and R&D company of injection medical devices in the field of aesthetic medicine. The company’s website states that its calcium hydroxyapatite filler can stimulate the production of natural collagen fibers in the body and increase the volume of the skin for up to two years.
Hyaluronic acid is known for its ability to retain water and help deliver important nutrients to skin tissues. According to the website, age causes the natural degradation of hyaluronic acid in the body, and hyaluronic acid products can help restore the smoothness and luster of the skin.
Luminera’s main product is HarmonyCa, an innovative facial dermal filler that combines cross-linked hyaluronic acid (HA) with embedded calcium hydroxyapatite (CaHA) microspheres. HAmonyCa is currently available in Israel and Brazil. The statement stated that Allergan Aesthetics will continue to develop Luminera products for its international and American markets.
Carrie Strom, senior vice president of AbbVie, said: “The increase in Luminera’s assets adds innovative technology and complements” the US company’s franchise rights. “We welcome the Luminera team because we will continue to build our global aesthetic company.”
Luminera Chairman Dadi Segal and CTO and CEO Eran Goldberg co-founded the company, Liat Goldshaid-Zmiri.
Siegel stated in the statement that “combining the key and innovative Luminera assets” with Allergan Aesthetics’ assets will “provide a wider range of products for our customers” and is a “further establishment and development of a global aesthetics company”. And cooperation” opportunities.
Post time: Aug-17-2021